… recipient age, type of MSC donor, type of cancer being treated, preparative therapy before
transplantation, and role of HLA mismatching which all could influence the clinical outcomes. …

… Hematopoietic stem-cell transplantation (hsct) was first performed in 1957 by E. Donnell
Thomas as a new form of cancer treatment1. Although initial attempts were largely unsuccessful, …

… for indications for hematopoietic cell transplantation (HCT). At the … HCT using blood progenitor
cells from the patient (… vital component of the therapeutic armamentarium against several …

… In the latter, HSCT is intended to eliminate malignant cells by the myeloablative effect of
cytotoxic therapy—comprising intensive chemotherapy and/or total body irradiation (TBI)—and …

… complications following allogeneic hematopoietic stem cell transplantation, despite novel …
in preemptive therapy and treatment of established CMV disease. Treatment decisions for …

… This manuscript is the seventh report from the European Society for Blood and Marrow
Transplantation (EBMT) on the indications for haematopoietic stem cell transplantation (HSCT) …

… Conditioning regimens have a crucial role in the pathogenesis as highlighted by the … of
cytotoxic drugs, such as busulfan or metabolites of cyclophosphamide (26). Chemotherapy drugs …

… The number of haematopoietic stem cell transplants … allogeneic haematopoietic stem cell
transplantation including … highlights achievements in the treatment of autoimmune diseases. …

… of graft rejection and graft versus host disease (GVHD). Initially, hematopoietic stem cell
transplantation (… (SCID) as the only available curative treatment. It was a challenging procedure, …

… has become a well-established lifesaving treatment procedure for many patients with … ,
hematopoietic stem cell transplantation is now integrated as an essential part in many treatment …